Jefferies Financial Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Buy
166,489
+109,767
+194% +$1.92M 0.02% 610
2026
Q1
$1.09M Buy
+56,722
New +$1.23M 0.01% 894
2025
Q3
– Sell
-16,483
Closed -$307K – 1680
2025
Q2
$307K Buy
16,483
+4,815
+41% +$95.4K ﹤0.01% 1024
2025
Q1
$224K Buy
11,668
+2,510
+27% +$73.5K ﹤0.01% 1335
2024
Q4
$330K Sell
9,158
-369,178
-98% -$12.5M ﹤0.01% 1234
2024
Q3
$16M Buy
378,336
+293,580
+346% +$12.4M 0.11% 111
2024
Q2
$3.41M Buy
84,756
+54,756
+183% +$2.28M 0.04% 399
2024
Q1
$1.06M Buy
+30,000
New +$804K 0.01% 804

Other funds holding TNDM

Jefferies Financial Group's TNDM Position: Q2 2026 in Review

Jefferies Financial Group increased its Tandem Diabetes Care (TNDM) stake by 194% in Q2 2026, buying an estimated $1.92M and bringing the position to 166,489 shares worth $2.51M. The position accounts for 0.02% of the portfolio, ranked #610.

Jefferies Financial Group first reported a position in TNDM in Q1 2024 and has held it in 8 quarters since. The position peaked at $16M in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Jefferies Financial Group held 166,489 shares of Tandem Diabetes Care worth $2.51M as of Q2 2026.
  • Jefferies Financial Group bought 109,767 Tandem Diabetes Care shares in Q2 2026, an estimated $1.92M.
  • Tandem Diabetes Care made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #610 holding.
  • Jefferies Financial Group first reported a position in Tandem Diabetes Care in Q1 2024 and has held it in 8 quarters since.
  • Jefferies Financial Group's Tandem Diabetes Care position peaked at $16M in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.